Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Geisbert

Showing results (241-250 of 279) with videos related to

Pageof 28
Sort By:
Science Translational Medicine|April 7, 2017
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibodyChad E Mire, Joan B Geisbert, Viktoriya Borisevich, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Science Translational Medicine|April 8, 2021
Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCRCassio M Fontes, Barbara D Lipes, Jason Liu, et al.
Journal of Virology|June 10, 2025
Monotherapy with antibody 1C3 partially protects Ebola virus-exposed macaquesGabriella Worwa, Carl W Davis, Sarah E Klim, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesisChristian S Stevens, Kasopefoluwa Y Oguntuyo, Shreyas Kowdle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Nature Medicine|September 5, 2017
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa feverChad E Mire, Robert W Cross, Joan B Geisbert, et al.
The Journal of Clinical Investigation|December 11, 2019
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and deathRobert W Cross, Rong Xu, Demetrius Matassov, et al.
Pageof 28

Showing results (241-250 of 279) with videos related to

Sort By:
Pageof 28
Science Translational Medicine|April 7, 2017
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibodyChad E Mire, Joan B Geisbert, Viktoriya Borisevich, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Science Translational Medicine|April 8, 2021
Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCRCassio M Fontes, Barbara D Lipes, Jason Liu, et al.
Journal of Virology|June 10, 2025
Monotherapy with antibody 1C3 partially protects Ebola virus-exposed macaquesGabriella Worwa, Carl W Davis, Sarah E Klim, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesisChristian S Stevens, Kasopefoluwa Y Oguntuyo, Shreyas Kowdle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Nature Medicine|September 5, 2017
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa feverChad E Mire, Robert W Cross, Joan B Geisbert, et al.
The Journal of Clinical Investigation|December 11, 2019
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and deathRobert W Cross, Rong Xu, Demetrius Matassov, et al.
Pageof 28